Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Aduhelm

Recent news which mentions Aduhelm

Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
Tickers BIIB ESALY
Tags lecanemab Benzinga ESALY
From Benzinga
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
Tickers BIIB
Tags Market News Alzheimer's disease News
From Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
Tickers BIIB
Tags Alzheimer’s Alzheimer's disease Government
From Benzinga
Aduhelm's 'Blockbuster Potential' Is Underappreciated, Says Biogen Analyst
Tickers BIIB
Tags BIIB Biotech Needham
From Benzinga
After Aduhelm Win, Biogen Touts Encouraging Data From Second Alzheimer's Candidate
Tickers BIIB IONS
Tags Briefs Biotech BIIB
From Benzinga
Analysis Shows Biogen-Eisai's Aduhelm Slows Cognitive, Functional Decline In Early Alzheimer's Patients
Tickers BIIB ESALF ESALY
Tags Briefs Health Care Aduhelm
From Benzinga
Biogen Shares Are Trading Lower As Cleveland Clinic, Mount Sinai Decline To Aduhelm Administration
Tickers BIIB
Tags Aduhelm Briefs Health Care
From Benzinga
FDA Requests Probe Into Staff Interactions With Biogen Ahead Of Aduhelm Approval
Tickers BIIB
Tags Market News News Benzinga
From Benzinga
FDA Narrows Label To Recommend Use Of Biogen's Aduhelm In Mild Alzheimer's Patients
Tickers BIIB ESALY
Tags Health Care Aduhelm Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.